241 related articles for article (PubMed ID: 16670767)
1. Putting cholesterol in its place: apoE and reverse cholesterol transport.
Mahley RW; Huang Y; Weisgraber KH
J Clin Invest; 2006 May; 116(5):1226-9. PubMed ID: 16670767
[TBL] [Abstract][Full Text] [Related]
2. HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway.
Matsuura F; Wang N; Chen W; Jiang XC; Tall AR
J Clin Invest; 2006 May; 116(5):1435-42. PubMed ID: 16670775
[TBL] [Abstract][Full Text] [Related]
3. Role of cholesteryl ester transfer protein in reverse cholesterol transport.
McPherson R; Marcel Y
Clin Cardiol; 1991 Feb; 14(2 Suppl 1):I31-4. PubMed ID: 2044257
[TBL] [Abstract][Full Text] [Related]
4. Impact of LDL apheresis on atheroprotective reverse cholesterol transport pathway in familial hypercholesterolemia.
Orsoni A; Villard EF; Bruckert E; Robillard P; Carrie A; Bonnefont-Rousselot D; Chapman MJ; Dallinga-Thie GM; Le Goff W; Guerin M
J Lipid Res; 2012 Apr; 53(4):767-75. PubMed ID: 22338009
[TBL] [Abstract][Full Text] [Related]
5. Scavenger receptor type BI potentiates reverse cholesterol transport system by removing cholesterol ester from HDL.
Kinoshita M; Fujita M; Usui S; Maeda Y; Kudo M; Hirota D; Suda T; Taki M; Okazaki M; Teramoto T
Atherosclerosis; 2004 Apr; 173(2):197-202. PubMed ID: 15064092
[TBL] [Abstract][Full Text] [Related]
6. The effect of cholesteryl ester transfer protein overexpression and inhibition on reverse cholesterol transport.
Tchoua U; D'Souza W; Mukhamedova N; Blum D; Niesor E; Mizrahi J; Maugeais C; Sviridov D
Cardiovasc Res; 2008 Mar; 77(4):732-9. PubMed ID: 18056760
[TBL] [Abstract][Full Text] [Related]
7. Effect of inhibiting cholesteryl ester transfer protein on the kinetics of high-density lipoprotein cholesteryl ester transport in plasma: in vivo studies in rabbits.
Kee P; Caiazza D; Rye KA; Barrett PH; Morehouse LA; Barter PJ
Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):884-90. PubMed ID: 16373610
[TBL] [Abstract][Full Text] [Related]
8. Postprandial lipemia enhances the capacity of large HDL2 particles to mediate free cholesterol efflux via SR-BI and ABCG1 pathways in type IIB hyperlipidemia.
Julia Z; Duchene E; Fournier N; Bellanger N; Chapman MJ; Le Goff W; Guerin M
J Lipid Res; 2010 Nov; 51(11):3350-8. PubMed ID: 20713650
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of the cholesteryl ester transfer protein-mediated uptake of high density lipoprotein cholesteryl esters by Hep G2 cells.
Rinninger F; Pittman RC
J Biol Chem; 1989 Apr; 264(11):6111-8. PubMed ID: 2539370
[TBL] [Abstract][Full Text] [Related]
10. The effects of cholesterol ester transfer protein inhibition on cholesterol efflux.
Tall AR
Am J Cardiol; 2009 Nov; 104(10 Suppl):39E-45E. PubMed ID: 19895943
[TBL] [Abstract][Full Text] [Related]
11. Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice.
Westerterp M; van der Hoogt CC; de Haan W; Offerman EH; Dallinga-Thie GM; Jukema JW; Havekes LM; Rensen PC
Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2552-9. PubMed ID: 16946130
[TBL] [Abstract][Full Text] [Related]
12. Roles of plasma lipid transfer proteins in reverse cholesterol transport.
Yamashita S; Sakai N; Hirano K; Ishigami M; Maruyama T; Nakajima N; Matsuzawa Y
Front Biosci; 2001 Mar; 6():D366-87. PubMed ID: 11229884
[TBL] [Abstract][Full Text] [Related]
13. Large and cholesteryl ester-rich high-density lipoproteins in cholesteryl ester transfer protein (CETP) deficiency can not protect macrophages from cholesterol accumulation induced by acetylated low-density lipoproteins.
Ishigami M; Yamashita S; Sakai N; Arai T; Hirano K; Hiraoka H; Kameda-Takemura K; Matsuzawa Y
J Biochem; 1994 Aug; 116(2):257-62. PubMed ID: 7822240
[TBL] [Abstract][Full Text] [Related]
14. Atheroprotective reverse cholesterol transport pathway is defective in familial hypercholesterolemia.
Bellanger N; Orsoni A; Julia Z; Fournier N; Frisdal E; Duchene E; Bruckert E; Carrie A; Bonnefont-Rousselot D; Pirault J; Saint-Charles F; Chapman MJ; Lesnik P; Le Goff W; Guerin M
Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1675-81. PubMed ID: 21527752
[TBL] [Abstract][Full Text] [Related]
15. Lipid transfer inhibitor protein defines the participation of lipoproteins in lipid transfer reactions: CETP has no preference for cholesteryl esters in HDL versus LDL.
Serdyuk AP; Morton RE
Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):718-26. PubMed ID: 10073979
[TBL] [Abstract][Full Text] [Related]
16. Postprandial chylomicrons: potent vehicles for transporting cholesterol from endogenous LDL+HDL and cell membranes to the liver via LCAT and CETP.
Chung BH; Liang P; Doran S; Cho BH; Franklin F
J Lipid Res; 2004 Jul; 45(7):1242-55. PubMed ID: 15102891
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological modulation of cholesteryl ester transfer protein, a new therapeutic target in atherogenic dyslipidemia.
Le Goff W; Guerin M; Chapman MJ
Pharmacol Ther; 2004 Jan; 101(1):17-38. PubMed ID: 14729390
[TBL] [Abstract][Full Text] [Related]
18. Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport.
Bruce C; Chouinard RA; Tall AR
Annu Rev Nutr; 1998; 18():297-330. PubMed ID: 9706227
[TBL] [Abstract][Full Text] [Related]
19. Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein.
Yamashita S; Hirano K; Sakai N; Matsuzawa Y
Biochim Biophys Acta; 2000 Dec; 1529(1-3):257-75. PubMed ID: 11111094
[TBL] [Abstract][Full Text] [Related]
20. Alterations in high-density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin:cholesterol acyltransferase and lipid transfer proteins.
Borggreve SE; De Vries R; Dullaart RP
Eur J Clin Invest; 2003 Dec; 33(12):1051-69. PubMed ID: 14636288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
